Showing results (81-90 of 99) with videos related to

Sort By:
Pageof 10
International Journal of Molecular Sciences|April 30, 2021
Hyperprogressive Disease: Main Features and Key ControversiesHugo Arasanz, Miren Zuazo, Ana Bocanegra, et al.
Virus Research|June 4, 2013
Immune modulation by genetic modification of dendritic cells with lentiviral vectorsTherese Liechtenstein, Noemi Perez-Janices, Christopher Bricogne, et al.
Cell Reports|August 24, 2017
PDL1 Signals through Conserved Sequence Motifs to Overcome Interferon-Mediated CytotoxicityMaria Gato-Cañas, Miren Zuazo, Hugo Arasanz, et al.
Oncotarget|February 9, 2017
CHL1 hypermethylation as a potential biomarker of poor prognosis in breast cancerEsperanza Martín-Sánchez, Saioa Mendaza, Ane Ulazia-Garmendia, et al.
Cancers|September 23, 2022
Immune Profiling Uncovers Memory T-Cell Responses with a Th17 Signature in Cancer Patients with Previous SARS-CoV-2 Infection Followed by mRNA VaccinationMiriam Echaide, Ibone Labiano, Marina Delgado, et al.
International Journal of Molecular Sciences|April 17, 2019
PD-L1 Expression in Systemic Immune Cell Populations as a Potential Predictive Biomarker of Responses to PD-L1/PD-1 Blockade Therapy in Lung CancerAna Bocanegra, Gonzalo Fernandez-Hinojal, Miren Zuazo-Ibarra, et al.
Oncotarget|August 19, 2015
Differential involvement of RASSF2 hypermethylation in breast cancer subtypes and their prognosisNoemi Perez-Janices, Idoia Blanco-Luquin, Natalia Torrea, et al.
International Journal of Molecular Sciences|September 9, 2022
How Can We Improve the Vaccination Response in Older People? Part II: Targeting Immunosenescence of Adaptive Immunity CellsMaider Garnica, Anna Aiello, Mattia Emanuela Ligotti, et al.
International Journal of Molecular Sciences|September 9, 2022
How Can We Improve Vaccination Response in Old People? Part I: Targeting Immunosenescence of Innate Immunity CellsAnna Aiello, Mattia Emanuela Ligotti, Maider Garnica, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|September 30, 2019
Short-Term Local Expression of a PD-L1 Blocking Antibody from a Self-Replicating RNA Vector Induces Potent Antitumor ResponsesMaria Cristina Ballesteros-Briones, Eva Martisova, Erkuden Casales, et al.
Pageof 10